P
PSYBF
vs
AMGN
AMGN
Over the past 12 months, PSYBF has underperformed AMGN, delivering a return of 0% compared to the AMGN's +21% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
AMGN
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
P
|
Psybio Therapeutics Corp
OTC:PSYBF
|
0.0001
USD
|
|||||
|
Amgen Inc
NASDAQ:AMGN
|
342.655
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
PSYBF, AMGN
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
P
|
Psybio Therapeutics Corp
Revenue
|
|||||||||||
|
Amgen Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
PSYBF, AMGN
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
P
|
Psybio Therapeutics Corp
OTC:PSYBF
|
|||||||||
|
Amgen Inc
NASDAQ:AMGN
|
|||||||||
Compare company's free cash flow with its competitors.
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
PSYBF, AMGN
Performance By Year
PSYBF, AMGN
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.